menu-iconbanner-menu-icon-open

BIS

UltraShort Nasdaq Biotechnology

Investment Objective

ProShares UltraShort Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology® Index.

How to buy
View all Fund detail sections
Important Considerations

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”).

While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance.

For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target.

The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

Common uses for magnified exposure

  • Seeking magnified gains (will also magnify losses)

  • Getting a target level of exposure for less cash

  • Overweighting a market segment without additional cash

Documents & Downloads
Fund Fact Sheet
This links to a pdf file This link opens a new window
Annual Report
This links to a pdf file This link opens a new window
Semi Annual Report
This links to a pdf file This link opens a new window
NAV History
This links to a pdf file This link opens a new window

You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Month-End Total Returns as of 11/30/2024
Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIS Market Price -0.81% 10.39% -10.03% -9.88% -29.44% -6.13% -21.25% -21.43% -31.99% 04/07/2010
BIS NAV -0.24% 10.92% -9.29% -9.52% -29.30% -6.01% -21.20% -21.41% -31.98% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIS
  • Intraday Ticker
    BIS.IV
  • CUSIP
    74347G838
  • Inception Date
    4/7/10
  • Gross Expense Ratio
    2.42%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 12/20/2024
  • NAV
    $18.24
  • NAV Change
    $-0.32 down caret
  • Market Price
    $18.26
  • Market Price Change
    $-0.27 down caret
  • Trading Volume (M)
    14,382
  • 30-Day Median Bid Ask Spread
    0.22%
  • View Premium / Discount
Snapshot
  • Ticker
    BIS
  • Intraday Ticker
    BIS.IV
  • CUSIP
    74347G838
  • Inception Date
    4/7/10
  • Expense Ratio
    0.95%
  • Gross Expense Ratio
    2.42%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 12/20/2024
  • NAV
    $18.24
  • NAV Change
    $-0.32 down caret
  • Market Price
    $18.26
  • Market Price Change
    $-0.27 down caret
  • Trading Volume (M)
    14,382
  • 30-Day Median Bid Ask Spread
    0.22%
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2025. Without the fee waiver performance would likely be lower.

 

Exposures

Index as of 9/30/2024

Holdings

as of 12/20/2024

Exposure Weight Ticker Description Exposure Value
(Notional + GL)		 Market Value Shares/Contracts SEDOL Number
-- -- TREASURY BILL -- $1,486,329.69 1,500,000 BNDXZ56
-- -- NET OTHER ASSETS (LIABILITIES) -- $2,500,863.44 2,500,863 --
-6.41% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA -255,395 -- -59 --
-12.49% -- NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC -497,804 -- -115 --
-17.04% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA -679,611 -- -157 --
-32.03% -- NASDAQ BIO INDEX SWAP BNP PARIBAS -1,276,975 -- -295 --
-55.04% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE -2,194,666 -- -507 --
-76.97% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG -3,069,070 -- -709 --
Download Holdings (.csv)This links to a pdf fileThis link opens a new window

Index

as of 9/30/2024

  • Total Number of Companies214
  • Price/Earnings Ratio--
  • Price/Book Ratio4.157
  • Dividend Yield ( % )0.88
  • Avg. Index Market Capitalization$7.59 billion
About the Index

The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.

Distributions

For

2024
  • 2024
  • 2023
  • 2020
  • 2019
  • 2018
Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital

Portfolio Hedging Series

Part I: The Significance of Portfolio Hedging

Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More

Part II: Strategies for Hedging Your Portfolio

Part III: The Efficacy of Hedging with Inverse ETFs
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to -2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Short ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Short ProShares ETFs should lose money when their benchmarks rise. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.